SPOTCHEM II Basic PANEL-1 Reagent Test Strip and SPOTCHEM II Glucose Reagent Test Strip 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Arkray Factory Inc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2016-01-29
  • 사례 출판 날짜
    2016-01-29
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: arkray factory inc spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip the united states food and drug administration (fda) has issued an alert concerning the spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip [lot numbers: pn5c26 and ea4m78; manufacturing dates: november 2014 to september 2015; distribution dates: 18 february 2015 to 13 october 2015], manufactured by arkray factory inc. according to the fda, the manufacturer is recalling the spotchem ii basic panel-1 reagent test strip and spotchem ii glucose reagent test strip because they may report falsely low blood glucose levels when the true levels are above 265 mg/dl. there is a risk that the health care provider would not diagnose hyperglycemia (high blood sugar) including diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome in a timely manner and fail to treat elevated blood glucose levels. the issue may cause serious injury or death. the manufacturer sent an urgent medical device recall letter to customers in the united states beginning on 18 december 2015. the letter identified affected product, stated the reason for recall and provided instructions for returning unused product to the firm. tfor details, please refer to the fda websites: http://www.Accessdata.Fda.Gov/scripts/enforcement/enforce_rpt-event-detail.Cfm?action=detail&id=72867&w=01202016%e2%8c%a9=eng http://www.Fda.Gov/safety/medwatch/safetyinformation/safetyalertsforhumanmedicalproducts/ucm483792.Htm http://www.Fda.Gov/medicaldevices/safety/listofrecalls/ucm483760.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 29 january 2016.

Device

Manufacturer